CONMED Q4 Earnings Call Highlights [Yahoo! Finance]
CONMED Corporation (CNMD)
Last conmed corporation earnings: 4/29 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
conmed.com/en/about-us/investors/investor-relations
Company Research
Source: Yahoo! Finance
to $0.54 from $1.08 last year but adjusted diluted EPS rose to $1.43 in Q4 and $4.59 for the full year. Management announced a strategic exit from gastroenterology that will cause near-term earnings dilution (guidance shows a $0.45–$0.50 EPS headwind for 2026) while emphasizing three growth platforms—AirSeal, Buffalo Filter (smoke evacuation) and BioBrace—for long-term margin expansion. 2026 guidance targets revenue of $1.345–$1.375 billion (organic growth ~4.5%–6%) and adjusted EPS of $4.30–$4.45 , with tariff headwinds and portfolio changes offset by share-repurchase plans (dividend suspended; $150M repurchase authorized) and projected free cash flow of roughly $125 million. Interested in CONMED Corporation? Here are five stocks we like better. Med-tech stock Conmed dips ahead of big Q4 report...opportunity? CONMED (NYSE:CNMD) reported fourth-quarter fiscal 2025 sales of $373.2 million, representing a 7.9% year-over-year increase as reported and 7.1% growth in constant cur
Show less
Read more
Impact Snapshot
Event Time:
CNMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CNMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CNMD alerts
High impacting CONMED Corporation news events
Weekly update
A roundup of the hottest topics
CNMD
News
- CONMED (NYSE:CNMD) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.MarketBeat
- CONMED (NYSE:CNMD) had its price target raised by analysts at Wells Fargo & Company from $41.00 to $42.00. They now have an "equal weight" rating on the stock.MarketBeat
- CONMED (NYSE:CNMD) had its "hold" rating reaffirmed by analysts at Needham & Company LLC.MarketBeat
- Conmed Corp (CNMD) Q4 2025 Earnings Call Highlights: Strong Orthopedic Sales Drive Growth ... [Yahoo! Finance]Yahoo! Finance
- Conmed outlines 2026 revenue target of $1.345B–$1.375B while advancing portfolio focus and supply chain improvements [Seeking Alpha]Seeking Alpha
CNMD
Earnings
- 1/28/26 - Beat
CNMD
Sec Filings
- 1/28/26 - Form 8-K
- 1/12/26 - Form 8-K
- 1/8/26 - Form 8-K
- CNMD's page on the SEC website